President Trump has proposed a one hundred per cent tariff on branded and patented pharmaceutical imports, due to take effect unless manufacturers shift production to the United States by October 2025. The measure is part of a wider plan to rebuild domestic manufacturing and reduce the US trade deficit. Officials say it will strengthen national security, but the pharmaceutical industry has warned of major disruption to global supply chains and rising drug prices across Europe and beyond. ...
All content for The Commercial Awareness Compass by AllAboutLaw is the property of AllAboutLaw and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
President Trump has proposed a one hundred per cent tariff on branded and patented pharmaceutical imports, due to take effect unless manufacturers shift production to the United States by October 2025. The measure is part of a wider plan to rebuild domestic manufacturing and reduce the US trade deficit. Officials say it will strengthen national security, but the pharmaceutical industry has warned of major disruption to global supply chains and rising drug prices across Europe and beyond. ...
Biscuit boom: Pladis’ £68m recipe for UK growth | Commercial Awareness Compass #43
The Commercial Awareness Compass by AllAboutLaw
24 minutes
3 months ago
Biscuit boom: Pladis’ £68m recipe for UK growth | Commercial Awareness Compass #43
Pladis, the owner of household favourites like McVitie’s, Jacob’s and Jaffa Cakes, is investing £68 million to modernise its UK manufacturing base. The plan includes automated production lines, upgraded infrastructure, and reduced carbon emissions across sites in Liverpool, Stockport, and Carlisle. By the end of 2026, the company expects not only to boost productivity and capacity but also to create new jobs. This is more than an upgrade of snack production. It touches on themes of auto...
The Commercial Awareness Compass by AllAboutLaw
President Trump has proposed a one hundred per cent tariff on branded and patented pharmaceutical imports, due to take effect unless manufacturers shift production to the United States by October 2025. The measure is part of a wider plan to rebuild domestic manufacturing and reduce the US trade deficit. Officials say it will strengthen national security, but the pharmaceutical industry has warned of major disruption to global supply chains and rising drug prices across Europe and beyond. ...
